P-2202
- Generic Name
- P-2202
A Clinical Trial to Study the Efficacy, Safety, Tolerability and Pharmacokinetics of P2202 in Patients of Type 2 Diabetes
- First Posted Date
- 2012-08-28
- Last Posted Date
- 2013-08-05
- Lead Sponsor
- Piramal Enterprises Limited
- Target Recruit Count
- 48
- Registration Number
- NCT01674348
- Locations
- 🇨🇦
LMC Endocrinolgy Centres Ltd, Toronto, Ontario, Canada
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath